SCHEMBL4958602

SCHEMBL4958602

COc1c(OCC2CO2)cccc1-c1c(Cl)cccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
GLA P06280 1/20 0.49
DRD4 P21917 5/20 0.44
CYP3A4 P08684 2/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
ADRA2C P18825 1/20 0.38
PTPN1 P18031 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
PKM P14618 1/20 0.36
ADRA1D P25100 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958593 1.00 ALDH1A1 (0.49) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL4957535 0.85 AQP1 (0.42) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL4957528 0.85 AQP1 (0.42) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL19612271 0.83 ALDH1A1 (0.64) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL4958905 0.83 ALDH1A1 (0.45) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL4958908 0.83 ALDH1A1 (0.45) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL19612301 0.80 ALDH1A1 (0.56) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL11364007 0.80 ALDH1A1 (0.60) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL18812894 0.79 ALDH1A1 (0.54) ALDH1A1GLADRD4CYP3A4TP53
SCHEMBL19612508 0.77 ALDH1A1 (0.60) ALDH1A1GLADRD4CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871759-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2006116158-A1 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A ALDH1A1 814/4885GLA 3732/4885DRD4 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.